+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The Vesicular Monoamine Transporter, in Contrast to the Dopamine Transporter, Is Not Altered by Chronic Cocaine Self-Administration in the Rat



The Vesicular Monoamine Transporter, in Contrast to the Dopamine Transporter, Is Not Altered by Chronic Cocaine Self-Administration in the Rat



The Journal of Neuroscience 16(10): 3507-3510




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067938760

Download citation: RISBibTeXText

DOI: 10.1523/jneurosci.16-10-03507.1996


Related references

The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat. Journal of Neuroscience 16(10): 3507-3510, 1996

The vesicular monoamine transporter, in contrast to the dopamine transporter, is not regulated following chronic cocaine self-administration. Society for Neuroscience Abstracts 21(1-3): 1382, 1995

Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Annals of Neurology 40(3): 428-439, 1996

Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Molecular Pharmacology 47(2): 368-373, 1995

Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration. Molecular Brain Research. 49(1-2): 137-148, 1997

Decreased vesicular monoamine transporter type 2 availability in the striatum following chronic cocaine self-administration in nonhuman primates. Biological Psychiatry 77(5): 488-492, 2015

Increased dopamine D2High receptors in knockouts of the dopamine transporter and the vesicular monoamine transporter may contribute to spontaneous hyperactivity and dopamine supersensitivity. Synapse 61(7): 573-576, 2007

Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain. Plos one 7(11): E49483, 2012

Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons. Journal of Neurochemistry 111(5): 1202-1212, 2009

Altered dopamine transporter function and phosphorylation following chronic cocaine self-administration and extinction in rats. Biochemical and Biophysical Research Communications 391(3): 1517-1521, 2010

Coordinated expression of dopamine transporter and vesicular monoamine transporter in the primate striatum during development. Synapse 67(9): 580-585, 2013

Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease. Methods in Molecular Medicine 62: 179-190, 2001

Age-related decreases in striatal dopamine transporter and vesicular monoamine transporter binding sites in alcoholics. Alcoholism Clinical & Experimental Research 22(3 ABSTR Suppl. ): 48A, 1998

Coordinated expression of dopamine transporter DAT and vesicular monoamine transporter VMAT2 in the primate striatum during development. 2013

Aging effects on locomotor activity in dopamine transporter and vesicular monoamine transporter knockout mice. Society for Neuroscience Abstracts 26(1-2): Abstract No -344 5, 2000